Countries North America
Somite.ai Secures Strategic Investment from AMD Ventures to Advance Foundation Models for Cell Therapy
Somite.ai, a company pioneering foundation models for human stem cells, announced a strategic investment from AMD Ventures, following Somite's $...
August 21, 2025 | News
Thermo Fisher Launches Gibco™ Expi293™ PRO System to Transform Protein Expression
Thermo Fisher Scientific has introduced the Gibco™ Expi293™ PRO Expression System, a next-generation HEK293 transient expression system designe...
August 20, 2025 | News
LabConnect Launches LabConnector™ to Transform Clinical Trial Data Management
LabConnect, LLC, a global leader in central laboratory services for clinical trials, announced the launch of LabConnector™, a powerful new techn...
August 20, 2025 | News
South Korea’s Avixgen, Subsidiary of Dx&Vx, Signs $360M Licensing-Out Deal with U.S. Biotech for ACP Drug Delivery Platform
This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. DXVX is taki...
August 19, 2025 | News
Anixa Biosciences Advances Phase 1 Trial of FSHR-Targeted CAR-T Therapy for Recurrent Ovarian Cancer
Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer, announced that the second patient in th...
August 19, 2025 | News
Novo Nordisk Expands U.S. Access to FDA-Approved Ozempic® with $499 Monthly Offer for Uninsured Patients
Offer supports access for eligible patients without insurance to FDA-approved Ozempic® (semaglutide) injection 0.5 mg, 1 mg,...
August 19, 2025 | News
Genprex Secures Key U.S. and European Patents for REQORSA® Gene Therapy in Combination with Checkpoint Inhibitors
Genprex, Inc., a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced t...
August 19, 2025 | News
SineuGene Secures Dual U.S. and China IND Clearances for First-in-Class ALS Gene Therapy SNUG01
SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, anno...
August 18, 2025 | News
Philips to Invest $150M in U.S. Manufacturing and R&D to Advance AI-Enabled Ultrasound and Create Over 270 Jobs
Philips, a global leader in health technology, announced a plan for new investments of more than USD 150 million in U.S. manufacturing and research an...
August 15, 2025 | News
Superluminal Medicines and Eli Lilly Forge $1.3 Billion Collaboration on Undisclosed GPCR Targets in Cardiometabolic Disease and Obesity
Collaboration focused on undisclosed GPCR targets Company to receive an upfront and near-term payments, including an equity investment, as...
August 15, 2025 | News
ProBio Launches GMP AAV Manufacturing Services at New Jersey Facility to Accelerate Gene Therapy Development
ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, announced the launch of its cGMP Adeno-...
August 12, 2025 | News
Thermo Fisher’s Oncomine Dx Target Test Wins FDA Approval to Identify HER2-Mutant NSCLC Patients for HERNEXEOS®
Oncomine Dx Target Test approved to identify patients eligible for HERNEXEOS® (zongertinib tablets), the first and only orally administered target...
August 12, 2025 | News
GenScript Launches ‘Scripting Possibilities’—A Bold Global Brand Identity to Power the Future of Life Sciences
GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, unveiled its new global brand platform: Scripting Possibilities...
August 11, 2025 | News
SOPHiA GENETICS and AstraZeneca Expand AI Collaboration to Advance Personalised Breast Cancer Care
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine,announced an expansion of its...
August 06, 2025 | News
Most Read
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
